Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk

It is known that healthy women during childbearing years have a lower risk of cardiovascular disease (CVD) and coronary heart disease compared to age matched men. Various traditional risk factors have been shown to confer differential CVD susceptibilities by sex. Atherosclerosis is a major cause of...

Full description

Bibliographic Details
Main Authors: George A. Robinson, Ines Pineda-Torra, Coziana Ciurtin, Elizabeth C. Jury
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.914016/full
_version_ 1828821043379175424
author George A. Robinson
George A. Robinson
Ines Pineda-Torra
Coziana Ciurtin
Coziana Ciurtin
Elizabeth C. Jury
author_facet George A. Robinson
George A. Robinson
Ines Pineda-Torra
Coziana Ciurtin
Coziana Ciurtin
Elizabeth C. Jury
author_sort George A. Robinson
collection DOAJ
description It is known that healthy women during childbearing years have a lower risk of cardiovascular disease (CVD) and coronary heart disease compared to age matched men. Various traditional risk factors have been shown to confer differential CVD susceptibilities by sex. Atherosclerosis is a major cause of CVD and mortality and sex differences in CVD risk could be due to reduced atherogenic low and very low-density lipoproteins (LDL and VLDL) and increased atheroprotective high density lipoproteins (HDLs) in women. In contrast, patients with systemic lupus erythematosus (SLE), a chronic inflammatory disease that predominately affects women, have an increased atherosclerotic and CVD risk. This increased CVD risk is largely associated with dyslipidaemia, the imbalance of atherogenic and atheroprotective lipoproteins, a conventional CVD risk factor. In many women with SLE, dyslipidaemia is characterised by elevated LDL and reduced HDL, eradicating the sex-specific CVD protection observed in healthy women compared to men. This review will explore this paradox, reporting what is known regarding sex differences in lipid metabolism and CVD risk in the healthy population and transgender individuals undergoing cross-sex hormone therapy, and provide evidence for how these differences may be compromised in an autoimmune inflammatory disease setting. This could lead to better understanding of mechanistic changes in lipid metabolism driving the increased CVD risk by sex and in autoimmunity and highlight potential therapeutic targets to help reduce this risk.
first_indexed 2024-12-12T12:47:06Z
format Article
id doaj.art-868a11451a4c426db94ac71e8db56a7e
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-12T12:47:06Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-868a11451a4c426db94ac71e8db56a7e2022-12-22T00:24:05ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-05-01910.3389/fmed.2022.914016914016Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease RiskGeorge A. Robinson0George A. Robinson1Ines Pineda-Torra2Coziana Ciurtin3Coziana Ciurtin4Elizabeth C. Jury5Division of Medicine, Centre for Rheumatology Research, University College London, London, United KingdomDivision of Medicine, Centre for Adolescent Rheumatology Versus Arthritis, University College London, London, United KingdomDivision of Medicine, Centre for Cardiometabolic and Vascular Science, University College London, London, United KingdomDivision of Medicine, Centre for Rheumatology Research, University College London, London, United KingdomDivision of Medicine, Centre for Adolescent Rheumatology Versus Arthritis, University College London, London, United KingdomDivision of Medicine, Centre for Rheumatology Research, University College London, London, United KingdomIt is known that healthy women during childbearing years have a lower risk of cardiovascular disease (CVD) and coronary heart disease compared to age matched men. Various traditional risk factors have been shown to confer differential CVD susceptibilities by sex. Atherosclerosis is a major cause of CVD and mortality and sex differences in CVD risk could be due to reduced atherogenic low and very low-density lipoproteins (LDL and VLDL) and increased atheroprotective high density lipoproteins (HDLs) in women. In contrast, patients with systemic lupus erythematosus (SLE), a chronic inflammatory disease that predominately affects women, have an increased atherosclerotic and CVD risk. This increased CVD risk is largely associated with dyslipidaemia, the imbalance of atherogenic and atheroprotective lipoproteins, a conventional CVD risk factor. In many women with SLE, dyslipidaemia is characterised by elevated LDL and reduced HDL, eradicating the sex-specific CVD protection observed in healthy women compared to men. This review will explore this paradox, reporting what is known regarding sex differences in lipid metabolism and CVD risk in the healthy population and transgender individuals undergoing cross-sex hormone therapy, and provide evidence for how these differences may be compromised in an autoimmune inflammatory disease setting. This could lead to better understanding of mechanistic changes in lipid metabolism driving the increased CVD risk by sex and in autoimmunity and highlight potential therapeutic targets to help reduce this risk.https://www.frontiersin.org/articles/10.3389/fmed.2022.914016/fullsex and genderlipoproteinsautoimmunityatherosclerosisSLE
spellingShingle George A. Robinson
George A. Robinson
Ines Pineda-Torra
Coziana Ciurtin
Coziana Ciurtin
Elizabeth C. Jury
Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
Frontiers in Medicine
sex and gender
lipoproteins
autoimmunity
atherosclerosis
SLE
title Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
title_full Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
title_fullStr Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
title_full_unstemmed Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
title_short Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
title_sort sex differences in lipid metabolism implications for systemic lupus erythematosus and cardiovascular disease risk
topic sex and gender
lipoproteins
autoimmunity
atherosclerosis
SLE
url https://www.frontiersin.org/articles/10.3389/fmed.2022.914016/full
work_keys_str_mv AT georgearobinson sexdifferencesinlipidmetabolismimplicationsforsystemiclupuserythematosusandcardiovasculardiseaserisk
AT georgearobinson sexdifferencesinlipidmetabolismimplicationsforsystemiclupuserythematosusandcardiovasculardiseaserisk
AT inespinedatorra sexdifferencesinlipidmetabolismimplicationsforsystemiclupuserythematosusandcardiovasculardiseaserisk
AT cozianaciurtin sexdifferencesinlipidmetabolismimplicationsforsystemiclupuserythematosusandcardiovasculardiseaserisk
AT cozianaciurtin sexdifferencesinlipidmetabolismimplicationsforsystemiclupuserythematosusandcardiovasculardiseaserisk
AT elizabethcjury sexdifferencesinlipidmetabolismimplicationsforsystemiclupuserythematosusandcardiovasculardiseaserisk